Concepedia

Edward G. Saravolac

EG

Statistics

Publications

11

Citations

774

H-Index

11

Active since

1991

Affiliations

Johnson & Johnson (Australia)(Current)

Department of National Defence

Inimex Pharmaceuticals (Canada)

University of British Columbia

Defence Research and Development Canada

Edward G. Saravolac is an author at Johnson & Johnson (Australia) specializing in immunology, infectious diseases, and life sciences.

Publications per year

1991–2014

11

Publications

11

Cationic lipid-mediated transfection of cells in culture requires mitotic activity

I Mortimer, Pat Tam, Ian MacLachlan et al. · Gene Therapy · 1999 · 252 citations

, , +14

Cellular Uptake, Distribution, and Stability of 10-23 Deoxyribozymes

Crispin R. Dass, Edward G. Saravolac, Yang Li et al. · Antisense and Nucleic Acid Drug Development · 2002 · 138 citations

, , +4

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

Y P Zhang, Laura Sekirov, Edward G. Saravolac et al. · Gene Therapy · 1999 · 109 citations

, , +16

Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice

Jonathan P. Wong, Edward G. Saravolac, Deana Sabuda et al. · Antimicrobial Agents and Chemotherapy · 1995 · 54 citations · Full text

, , +8

Purification of glucose-inducible outer membrane protein OprB of Pseudomonas putida and reconstitution of glucose-specific pores

Edward G. Saravolac, Norman Taylor, Roland Benz et al. · Journal of Bacteriology · 1991 · 50 citations · Full text

, , +17

1–5 of 11